Will Rosellini

I'm Will, a neuroscientist, inventor, and IP strategist who asks the questions patent attorneys don't: which feature must a competitor copy to be viable, and can we detect it in their product? I founded MicroTransponder, which developed the first FDA-approved vagus nerve stimulation therapy for stroke and PTSD, and took Perimeter Medical Imaging public as CEO. I hold 12+ U.S. patents and an Edison Award for neuroplasticity innovation. Now at SIM IP and PatentVest, I turn IP into investment-grade assets. Ask me about patent strategy for medical devices, neuromodulation and vagus nerve stimulation, building IP portfolios that hold up in court, and SBIR/DARPA funding.